Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 821-830 of 969 for hematology

Edit search filters
  1. A Study to Measure Hemolysis Markers in Subjects with Warm Autoimmune Hemolytic Anemia

    Rochester, MN

  2. A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

  3. A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia

    Rochester, MN

  4. Myeloproliferative Neoplasms (MPN) Socioeconomic Study

    Rochester, MN

  5. A Study to Create and Maintain Plasma and Serum Bank for Patients with Thrombosis

    Rochester, MN

  6. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls

    Rochester, MN

  7. A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders

    Rochester, MN

  8. Methylation and Chromatin Abnormalities in Myelodysplastic Syndromes and Chronic Myelomonocytic leukemia.

    Rochester, MN

  9. Correlative Biomarker Study in Patients With Myeloproliferative Disorders

    Scottsdale/Phoenix, AZ

  10. Prognostic and Predictive Biomarkers in Neuroendocrine Tumors

    Rochester, MN

.

Mayo Clinic Footer